NASDAQ$OPCH
Option Care Health, Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Option Care Health's financial performance for Q1 2023 showed strong growth and exceeded expectations.
Option Care Health reported a strong first quarter in 2023, with a 10.9% increase in net revenue, a 29.5% increase in net income, and a 20.6% increase in Adjusted EBITDA. The company also completed a $75.0 million stock repurchase and launched Naven Health.
- Net revenue increased by 10.9% to $1,015.8 million compared to Q1 2022.
- Net income rose by 29.5% to $39.2 million, with basic earnings per share at $0.22.
- Adjusted EBITDA grew by 20.6% to $93.8 million compared to the same period last year.
- Cash flow from operations increased to $89.8 million from $32.7 million in Q1 2022.
Headline financials
Revenue & EPS history
Option Care Health · Revenue · Quarterly
$1.02B
Forward guidance
Option Care Health updated its full year 2023 financial guidance, excluding the impact of the pending combination with Amedisys, Inc. The company expects to generate net revenue of $4.15 billion to $4.375 billion, Adjusted EBITDA of $380 million to $395 million, and cash flow from operations of at least $240 million.
Tailwinds
- Net Revenue of $4.15 billion to $4.375 billion
- Adjusted EBITDA of $380 million to $395 million
- Cash Flow from Operations of at least $240 million
- Effective tax rate of 27% - 29%
- Net interest expense of approximately $61.0 million to $65.0 million
Headwinds
- Guidance excludes the impact of the Company's pending combination with Amedisys, Inc.
- Uncertainty regarding material reconciling items between Adjusted EBITDA guidance and net income
- Changes in laws and regulations applicable to our business model
- Changes in market conditions and receptivity to our services and offerings
- Potential liability for claims not covered by insurance
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
-1.9%
Avg return
Earnings day
-4.2%
Avg return
5 days after
-1.9%
Avg return
30 days after
50%
36 / 72 earnings
Positive
+27.4%
Q3 2015
Best reaction
-53.6%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -24.3% | -20.7% | -22.4% | |
| Q4 2025 | -7.3% | -10.1% | -23.1% | |
| Q3 2025 | -8.7% | -5.7% | +8.5% | |
| Q1 2025 | -6.9% | -0.1% | -2.2% | |
| Q4 2024 | +1.6% | +4.1% | +6.4% | |
| Q3 2024 | -24.5% | -26.3% | -22.0% | |
| Q2 2024 | -1.9% | -5.3% | +2.1% | |
| Q1 2024 | -1.6% | -2.6% | -6.0% | |
| Q4 2023 | -3.4% | -1.8% | -2.0% | |
| Q3 2023 | -15.6% | -18.4% | -8.1% | |
| Q2 2023 | +5.3% | +4.0% | +7.9% | |
| Q1 2023 | -14.7% | -12.6% | -11.4% | |
| Q4 2022 | +7.1% | +6.3% | +9.4% | |
| Q3 2022 | -10.9% | -13.3% | -17.6% | |
| Q2 2022 | +5.0% | +4.8% | -2.2% | |
| Q1 2022 | +10.3% | +7.4% | +14.2% | |
| Q4 2021 | +8.6% | +10.8% | +20.9% | |
| Q3 2021 | -0.0% | -2.1% | -12.1% | |
| Q2 2021 | -0.1% | +8.3% | +35.1% | |
| Q1 2021 | -4.7% | -8.8% | +2.3% | |
| Q4 2020 | +2.2% | +1.9% | -3.7% | |
| Q3 2020 | +11.4% | +11.7% | +14.1% | |
| Q2 2020 | +3.6% | +1.7% | -2.8% | |
| Q1 2020 | +8.8% | +6.6% | +32.7% | |
| Q4 2019 | -12.8% | -16.1% | -48.4% | |
| Q3 2019 | -2.4% | -5.9% | -16.3% | |
| Q2 2019 | -1.4% | -5.2% | +21.5% | |
| Q1 2019 | -2.5% | -1.5% | -4.0% | |
| Q4 2018 | -33.0% | -38.7% | -50.4% | |
| Q3 2018 | +16.0% | +12.8% | +34.2% | |
| Q2 2018 | -1.5% | +2.5% | +4.4% | |
| Q1 2018 | -6.1% | -0.4% | +6.9% | |
| Q4 2017 | +3.3% | +0.0% | +9.8% | |
| Q3 2017 | -13.8% | -18.8% | +5.8% | |
| Q2 2017 | +8.6% | +21.8% | +6.8% | |
| Q1 2017 | +3.6% | +1.8% | +24.2% | |
| Q4 2016 | -12.3% | -10.6% | -33.9% | |
| Q3 2016 | -53.6% | -47.9% | -56.3% | |
| Q2 2016 | +3.0% | +2.6% | +2.3% | |
| Q1 2016 | +3.1% | — | — | |
| Q4 2015 | +7.1% | — | — | |
| Q3 2015 | +27.4% | — | — | |
| Q2 2015 | -22.8% | — | — | |
| Q1 2015 | -10.0% | — | — | |
| Q4 2014 | -11.3% | — | — | |
| Q3 2014 | +1.3% | — | — | |
| Q2 2014 | -4.4% | — | — | |
| Q1 2014 | +2.1% | — | — | |
| Q4 2013 | +6.3% | — | — | |
| Q2 1997 | +9.0% | — | — | |
| Q3 2013 | -4.6% | — | — | |
| Q2 2013 | -17.2% | — | — | |
| Q1 2013 | -0.1% | — | — | |
| Q4 2012 | -1.5% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | +11.0% | — | — | |
| Q1 2012 | +3.2% | — | — | |
| Q4 2011 | -1.5% | — | — | |
| Q3 2011 | -11.2% | — | — | |
| Q2 2011 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q1 2011 | -1.4% | — | — | |
| Q3 2010 | +8.1% | — | — | |
| Q2 2010 | -3.0% | — | — | |
| Q1 2009 | +0.9% | — | — | |
| Q1 2010 | +3.4% | — | — | |
| Q2 2009 | +2.6% | — | — | |
| Q4 2007 | +2.6% | — | — | |
| Q4 2009 | +2.6% | — | — | |
| Q3 2009 | +5.6% | — | — | |
| Q3 2008 | +5.6% | — | — | |
| Q4 2008 | +5.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro